Total records found: 885
Hide HeadlineShow Headline
Sort
Release Time Stock Code Stock Short Name Document
Release Time: 27/10/2026 17:36 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (90KB)
Release Time: 26/10/2026 18:17 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (89KB)
Release Time: 26/10/2026 08:00 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - ASCLETIS ANNOUNCES FDA IND SUBMISSION OF ASC39, AN ORAL SMALL MOLECULE SELECTIVE AMYLIN RECEPTOR AGONIST FOR THE TREATMENT OF OBESITY (39KB)
Release Time: 23/10/2026 18:02 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (89KB)
Release Time: 23/10/2026 08:00 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - ASCLETIS' STRATEGIC PARTNER SAGIMET ANNOUNCES FIRST PATIENT DOSED IN PHASE III U.S. CLINICAL TRIAL OF DENIFANSTAT (ASC40) FOR MODERATE TO SEVERE ACNE (39KB)
Release Time: 22/10/2026 17:05 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (89KB)
Release Time: 21/10/2026 17:19 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (89KB)
Release Time: 20/10/2026 17:42 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (89KB)
Release Time: 20/10/2026 08:00 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - ASCLETIS ANNOUNCES POSITIVE PRECLINICAL DATA FOR THE MOST COMPREHENSIVE ONCE-WEEKLY ORAL PEPTIDE PIPELINE FOR THE TREATMENT OF OBESITY (138KB)
Release Time: 16/10/2026 17:49 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (89KB)
Release Time: 15/10/2026 18:37 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (89KB)
Release Time: 14/10/2026 18:29 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (89KB)
Release Time: 13/10/2026 17:27 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (89KB)
Release Time: 12/10/2026 18:53 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (89KB)
Release Time: 06/10/2026 17:11 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026 (68KB)
Release Time: 02/10/2026 16:50 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - ASCLETIS' ASC36_35FDC DEMONSTRATED POTENTIAL FOR ONCE-MONTHLY TO ONCE-QUARTERLY DOSING AND ROBUST WEIGHT-LOSS IN PRECLINICAL STUDIES PRESENTED AT EASD 2026 (40KB)
Release Time: 29/09/2026 17:01 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Financial Statements/ESG Information - [Interim/Half-Year Report]
Interim Report 2026 (2MB)
Release Time: 29/09/2026 07:50 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - ASCLETIS ANNOUNCES POSITIVE RESULTS FROM 28-DAY PROOF-OF-CONCEPT CLINICAL STUDY IN U.S. FOR ASC50, A FIRST-IN-CLASS AND BEST-IN-CLASS ORAL SMALL MOLECULE IL-17A INHIBITOR FOR THE TREATMENT OF PLAQUE PSORIASIS (44KB)
Release Time: 08/09/2026 18:00 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - ASCLETIS ANNOUNCES INITIATION OF PHASE I STUDY IN U.S. FOR ORAL AMYLIN RECEPTOR PEPTIDE AGONIST ASC36 FOR THE TREATMENT OF OBESITY (40KB)
Release Time: 07/09/2026 12:00 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Announcements and Notices - [Other - Miscellaneous]
VOLUNTARY ANNOUNCEMENT - INCLUSION IN THE HONG KONG STOCK CONNECT LIST UNDER THE SHANGHAI-HONG KONG STOCK CONNECT AND THE SHENZHEN-HONG KONG STOCK CONNECT PROGRAMS (36KB)
Release Time: 03/09/2026 10:30 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2026 (68KB)
Release Time: 31/08/2026 21:14 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Announcements and Notices - [Interim Results]
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026 (205KB)
Release Time: 30/08/2026 18:05 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - ASCLETIS ANNOUNCES FIRST PARTICIPANT DOSED IN A GLOBAL PHASE III CLINICAL PROGRAM OF ONCE-DAILY ORAL SMALL MOLECULE GLP-1 RECEPTOR AGONIST ASC30 FOR CHRONIC WEIGHT MANAGEMENT (44KB)
Release Time: 21/08/2026 20:00 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Announcements and Notices - [Profit Warning / Inside Information]
PROFIT WARNING (41KB)
Release Time: 10/08/2026 18:50 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - ASCLETIS ANNOUNCES INITIATION OF TWO PHASE I STUDIES IN U.S. FOR THE TREATMENT OF OBESITY: ASC36 ONCE-MONTHLY INJECTION, AN AMYLIN RECEPTOR PEPTIDE AGONIST, AND ASC36_35FDC ONCE-MONTHLY INJECTION, A CO-FORMULATION OF ASC36 AND GLP-1R/GIPR PEPTIDE AGONIST ASC35 (44KB)
Release Time: 04/08/2026 12:16 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2026 (69KB)
Release Time: 03/08/2026 18:50 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - ASCLETIS ANNOUNCES INITIATION OF GLOBAL PHASE III FOR ORAL SMALL MOLECULE GLP-1, ASC30 AND POSITIVE PRECLINICAL DATA FOR ITS FIRST-IN-CLASS ORAL SMALL MOLECULE GLP-1/GIP/AMYLIN FIXED-DOSE COMBINATION (51KB)
Release Time: 03/08/2026 16:40 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Announcements and Notices - [Date of Board Meeting]
NOTICE OF BOARD MEETING (31KB)
Release Time: 30/07/2026 18:20 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (89KB)
Release Time: 29/07/2026 17:46 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (88KB)
Release Time: 28/07/2026 17:05 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (88KB)
Release Time: 27/07/2026 18:00 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - ASCLETIS ANNOUNCES ONCE-MONTHLY SUBCUTANEOUSLY ADMINISTERED GLP-1R/GIPR/GCGR TRIPLE PEPTIDE AGONIST, ASC37, DEMONSTRATED SUPERIOR WEIGHT LOSS IN A DIET-INDUCED OBESE MOUSE MODEL (42KB)
Release Time: 27/07/2026 17:06 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (88KB)
Release Time: 24/07/2026 18:07 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (88KB)
Release Time: 23/07/2026 08:00 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - ASCLETIS ANNOUNCES ORAL DISCUSSION OF ASC36_35 FDC PRECLINICAL DATA DEMONSTRATING SUPERIOR WEIGHT LOSS TO ELORALINTIDE/TIRZEPATIDE COMBINATION AT THE 62ND EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES (EASD) ANNUAL MEETING (412KB)
Release Time: 21/07/2026 18:06 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback / Others]
Next Day Disclosure Return (89KB)
Release Time: 20/07/2026 18:13 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (92KB)
Release Time: 17/07/2026 17:43 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (92KB)
Release Time: 15/07/2026 17:50 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - ASCLETIS SELECTS FOR CLINICAL DEVELOPMENT A FIXED-DOSE COMBINATION OF FIRST-IN-CLASS ORAL SMALL MOLECULE GIPR AGONIST, ASC48, AND ORAL SMALL MOLECULE GLP-1R AGONIST, ASC30 (42KB)
Release Time: 15/07/2026 17:15 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (92KB)
Release Time: 14/07/2026 17:32 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (92KB)
Release Time: 08/07/2026 17:34 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (92KB)
Release Time: 07/07/2026 17:11 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (92KB)
Release Time: 06/07/2026 08:00 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - ASCLETIS SUBMITS TWO IND APPLICATIONS TO THE U.S. FDA FOR THE TREATMENT OF OBESITY: ASC36 ONCE-MONTHLY INJECTION, A PEPTIDE AMYLIN RECEPTOR AGONIST, AND ASC36_35 FDC ONCE-MONTHLY INJECTION, A CO-FORMULATION OF ASC36 PLUS PEPTIDE GLP-1R/GIPR AGONIST ASC35 (42KB)
Release Time: 03/07/2026 12:36 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2026 (68KB)
Release Time: 30/06/2026 17:57 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (92KB)
Release Time: 30/06/2026 08:00 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Announcements and Notices - [Other - Miscellaneous]
VOLUNTARY ANNOUNCEMENT - PROPOSED SHARE REPURCHASE UNDER THE REPURCHASE MANDATE (38KB)
Release Time: 29/06/2026 19:09 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Constitutional Documents
THIRD AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION (299KB)
Release Time: 29/06/2026 19:02 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Announcements and Notices - [Results of AGM / Amendment of Constitutional Documents]
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON JUNE 29, 2026 (41KB)
Release Time: 26/06/2026 18:20 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (92KB)
Release Time: 25/06/2026 17:30 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (92KB)
Release Time: 24/06/2026 17:11 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (92KB)
Release Time: 23/06/2026 18:00 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - ASCLETIS ANNOUNCES U.S. FDA IND CLEARANCE FOR PHASE I STUDY OF ONCE-MONTHLY SUBCUTANEOUSLY ADMINISTERED GLP-1R/GIPR DUAL PEPTIDE AGONIST, ASC35, FOR THE TREATMENT OF OBESITY (42KB)
Release Time: 23/06/2026 17:13 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (92KB)
Release Time: 22/06/2026 18:03 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (92KB)
Release Time: 18/06/2026 18:12 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (91KB)
Release Time: 17/06/2026 19:21 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (91KB)
Release Time: 16/06/2026 18:43 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (91KB)
Release Time: 15/06/2026 17:38 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (91KB)
Release Time: 12/06/2026 18:26 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (90KB)
Release Time: 11/06/2026 18:28 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (90KB)
Release Time: 10/06/2026 18:25 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (90KB)
Release Time: 09/06/2026 18:12 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (90KB)
Release Time: 08/06/2026 18:53 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (90KB)
Release Time: 08/06/2026 08:00 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - ASCLETIS REINFORCES ITS DIFFERENTIATED OBESITY PORTFOLIO AT AMERICAN DIABETES ASSOCIATION (ADA) 2026 SCIENTIFIC SESSIONS, SHOWCASING ASC30 CLINICAL DATA AND EXCITING PRECLINICAL FINDINGS FROM ASC37 AND ASC39 (44KB)
Release Time: 05/06/2026 18:03 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (90KB)
Release Time: 05/06/2026 17:04 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Proxy Forms
FORM OF PROXY FOR THE 2026 ANNUAL GENERAL MEETING (58KB)
Release Time: 05/06/2026 17:03 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Announcements and Notices - [Notice of AGM / Closure of Books or Change of Book Closure Period]
NOTICE OF 2026 ANNUAL GENERAL MEETING (59KB)
Release Time: 05/06/2026 17:00 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Circulars - [General Mandate / Explanatory Statement for Repurchase of Shares / Re-election or Appointment of Director...
More
Circulars - [General Mandate / Explanatory Statement for Repurchase of Shares / Re-election or Appointment of Director subject to Shareholders' Approval / Amendment of Constitutional Documents]
]
PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES, RE-ELECTION OF RETIRING DIRECTORS, PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION AND NOTICE OF ANNUAL GENERAL MEETING (453KB)
Release Time: 04/06/2026 19:27 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (90KB)
Release Time: 03/06/2026 17:29 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (90KB)
Release Time: 02/06/2026 18:14 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (89KB)
Release Time: 02/06/2026 12:23 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Announcements and Notices - [Amendment of Constitutional Documents]
PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND ADOPTION OF THE THIRD AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION (122KB)
Release Time: 01/06/2026 17:39 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2026 (68KB)
Release Time: 07/05/2026 11:33 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026 (68KB)
Release Time: 06/05/2026 08:00 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - ASCLETIS TO PRESENT DATA ON MULTIPLE PROGRAMS AT THE 33RD EUROPEAN CONGRESS ON OBESITY (ECO 2026) (54KB)
Release Time: 30/04/2026 08:00 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - ASCLETIS TO PRESENT DATA ON MULTIPLE PROGRAMS AT THE AMERICAN DIABETES ASSOCIATION'S 2026 SCIENTIFIC SESSIONS (37KB)
Release Time: 29/04/2026 22:00 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Financial Statements/ESG Information - [Annual Report / Environmental, Social and Governance Information/Report]
Annual Report 2025 (6MB)
Release Time: 27/04/2026 08:00 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - ASCLETIS COMPLETES ENROLLMENT IN U.S. PHASE II STUDY OF ASC30, AN ORAL SMALL MOLECULE GLP-1R AGONIST, FOR THE TREATMENT OF DIABETES (39KB)
Release Time: 08/04/2026 12:19 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026 (68KB)
Release Time: 07/04/2026 18:50 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - ASCLETIS ANNOUNCES FIXED-DOSE COMBINATION OF ASC30, ONCE-DAILY ORAL SMALL MOLECULE GLP-1R AGONIST, AND ASC39, ONCE-DAILY ORAL SMALL MOLECULE AMYLIN-SELECTIVE AMYLIN RECEPTOR AGONIST, FOR CLINICAL DEVELOPMENT (39KB)
Release Time: 31/03/2026 22:17 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Announcements and Notices - [Final Results / Other - Business Update]
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025 AND CHANGE IN THE USE OF PROCEEDS (369KB)
Release Time: 18/03/2026 17:00 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Announcements and Notices - [Date of Board Meeting]
NOTICE OF BOARD MEETING (31KB)
Release Time: 17/03/2026 17:45 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - ORAL SMALL MOLECULE AMYLIN RECEPTOR AGONIST ASC39 DEMONSTRATED ELORALINTIDE-LIKE AMYLIN SELECTIVITY AND EFFICACY IN PRECLINICAL MODELS (43KB)
Release Time: 10/03/2026 17:45 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - ASCLETIS ANNOUNCES POSITIVE TOPLINE RESULTS FROM U.S. PHASE II, 24-WEEK STUDY FOR ITS ULTRA-LONG-ACTING SUBCUTANEOUS DEPOT FORMULATIONS OF SMALL MOLECULE GLP-1R AGONIST ASC30 FOR OBESITY (43KB)
Release Time: 03/03/2026 15:14 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2026 (69KB)
Release Time: 11/02/2026 07:00 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - ASCLETIS SELECTS ORAL AMYLIN RECEPTOR PEPTIDE AGONIST, ASC36, FOR CLINICAL DEVELOPMENT (40KB)
Release Time: 10/02/2026 18:10 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Others]
Next Day Disclosure Return (86KB)
Release Time: 10/02/2026 17:30 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Announcements and Notices - [Placing / Issue of Shares under a General Mandate]
COMPLETION OF PLACING OF NEW SHARES UNDER THE GENERAL MANDATE (49KB)
Release Time: 03/02/2026 18:55 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2026 (68KB)
Release Time: 03/02/2026 07:30 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Announcements and Notices - [Placing / Issue of Shares under a General Mandate]
PLACING OF NEW SHARES UNDER THE GENERAL MANDATE (77KB)
Release Time: 29/01/2026 18:50 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - ASCLETIS ANNOUNCES POSITIVE TOPLINE RESULTS FROM ITS PHASE III OPEN-LABEL STUDY OF DENIFANSTAT (ASC40), A FIRST-IN-CLASS, ONCE-DAILY ORAL FASN INHIBITOR FOR ACNE (39KB)
Release Time: 26/01/2026 08:00 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - ASCLETIS ANNOUNCES FIRST PARTICIPANTS DOSED IN A 13-WEEK U.S. PHASE II STUDY WITH ASC30, AN ORAL SMALL MOLECULE GLP-1R AGONIST FOR THE TREATMENT OF DIABETES (40KB)
Release Time: 20/01/2026 17:50 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - ASCLETIS SELECTS A NEXT-GENERATION ONCE-MONTHLY SUBCUTANEOUSLY ADMINISTERED GLP-1R/GIPR/GCGR TRIPLE PEPTIDE AGONIST, ASC37, FOR CLINICAL DEVELOPMENT (40KB)
Release Time: 05/01/2026 12:39 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2025 (66KB)
Release Time: 05/01/2026 08:00 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - ASCLETIS ANNOUNCES U.S. FDA IND CLEARANCE FOR 13-WEEK PHASE II STUDY OF ITS ORAL SMALL MOLECULE GLP-1, ASC30, IN PARTICIPANTS WITH DIABETES (40KB)
Release Time: 31/12/2025 14:52 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (89KB)
Release Time: 30/12/2025 17:44 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (89KB)
Release Time: 29/12/2025 18:20 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (89KB)
Release Time: 24/12/2025 14:12 Stock Code: 01672 Stock Short Name: ASCLETIS-B Document:
Next Day Disclosure Returns - [Share Buyback]
Next Day Disclosure Return (89KB)
Showing 100 of 885 records
Showing 100 of 885 records
Disclaimer

Information contained in the materials available under the web page containing the hyperlink to this disclaimer is posted on this website for the purpose of providing information to the public in Hong Kong. It is not intended as investment advice and must not be relied on as such. It is the sole responsibility of any person who is located outside of Hong Kong to check and comply with all applicable laws and regulations before accessing and using the materials and information.

Please note that the web page contains materials and information provided to HKEX electronically (including information provided in electronic format) by listed issuers, new listing applicants and relevant parties and there is no agency, employee or partner relationship between HKEX and such parties. HKEX does not assume responsibility for screening, editing or monitoring such materials and the information contained in the materials. The information contained in the materials is not verified by HKEX.

HKEX and/or its subsidiaries take no responsibility for the materials and information available under the web page, make no representation as to their accuracy, reliability, completeness or ownership and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the information. Some materials may contain hyperlinks to external websites or web pages for which HKEX and/or its subsidiaries are not responsible. (Please see HKEX's "Hyperlink Policy").

Nothing herein shall constitute or be considered to be a limitation upon or a waiver of the privileges and immunities of HKEX and its subsidiaries, which are specifically reserved.

Copyright exists in the information and materials available under the web page and may belong to HKEX, to the author or to any other party depending on the circumstances of publications. Reproduction, distribution, use and/or linking without consent from the relevant parties is not permitted.

If you believe or are aware that any information contained in the materials is inaccurate, erroneous, unlawful, obscene, defamatory or infringes any intellectual property rights of a third party, please contact HKEX e-Submission by email at: ESSHotline@hkex.com.hk.